Stifel Financial
VKTX icon

Stifel Financial’s Viking Therapeutics VKTX Stock Holding History

Stifel Financial’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8M Buy
354,583
+14,062
+4% +$454K 0.01% 838
2026
Q1 		$11.1M Buy
340,521
+3,701
+1% +$119K 0.01% 898
2025
Q4 		$11.8M Sell
336,820
-13,547
-4% -$480K 0.01% 872
2025
Q3 		$9.21M Sell
350,367
-26,081
-7% -$778K 0.01% 989
2025
Q2 		$9.98M Buy
376,448
+22,998
+7% +$605K 0.01% 882
2025
Q1 		$8.54M Buy
353,450
+174,631
+98% +$5.52M 0.01% 908
2024
Q4 		$7.2M Buy
178,819
+47,471
+36% +$2.71M 0.01% 1013
2024
Q3 		$8.32M Buy
131,348
+62,956
+92% +$3.69M 0.01% 924
2024
Q2 		$3.63M Buy
68,392
+44,511
+186% +$2.92M ﹤0.01% 1326
2024
Q1 		$1.96M Buy
23,881
+13,644
+133% +$607K ﹤0.01% 1736
2023
Q4 		$191K Buy
+10,237
New +$134K ﹤0.01% 3070
2021
Q4 		– Sell
-20,766
Closed -$130K – 3475
2021
Q3 		$130K Sell
20,766
-100
-0.5% -$618 ﹤0.01% 3210
2021
Q2 		$125K Sell
20,866
-9,442
-31% -$56.1K ﹤0.01% 3214
2021
Q1 		$192K Buy
30,308
+10,676
+54% +$75.1K ﹤0.01% 3028
2020
Q4 		$111K Sell
19,632
-782
-4% -$4.74K ﹤0.01% 2927
2020
Q3 		$119K Buy
20,414
+689
+3% +$4.74K ﹤0.01% 2732
2020
Q2 		$142K Sell
19,725
-1,142
-5% -$7.58K ﹤0.01% 2661
2020
Q1 		$99K Sell
20,867
-13,987
-40% -$86K ﹤0.01% 2592
2019
Q4 		$290K Buy
34,854
+12,991
+59% +$94.7K ﹤0.01% 2547
2019
Q3 		$162K Sell
21,863
-330
-1% -$2.45K ﹤0.01% 2693
2019
Q2 		$189K Sell
22,193
-623
-3% -$5.32K ﹤0.01% 2731
2019
Q1 		$233K Buy
22,816
+502
+2% +$4.2K ﹤0.01% 2518
2018
Q4 		$176K Buy
22,314
+5,237
+31% +$62.6K ﹤0.01% 2485
2018
Q3 		$298K Sell
17,077
-9,978
-37% -$119K ﹤0.01% 2363
2018
Q2 		$258K Buy
+27,055
New +$180K ﹤0.01% 2394

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Stifel Financial's VKTX Position: Q2 2026 in Review

Stifel Financial increased its Viking Therapeutics (VKTX) stake by 4.1% in Q2 2026, buying an estimated $454K and bringing the position to 354,583 shares worth $13.8M. The position accounts for 0.01% of the portfolio, ranked #838.

Stifel Financial first reported a position in VKTX in Q2 2018 and has held it in 25 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Stifel Financial held 354,583 shares of Viking Therapeutics worth $13.8M as of Q2 2026.
  • Stifel Financial bought 14,062 Viking Therapeutics shares in Q2 2026, an estimated $454K.
  • Viking Therapeutics made up 0.01% of Stifel Financial's portfolio in Q2 2026, its #838 holding.
  • Stifel Financial first reported a position in Viking Therapeutics in Q2 2018 and has held it in 25 quarters since.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.